Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesPharmaceutical policies: effects of cap and co-payment on rational drug useComparative safety of antidepressant agents for children and adolescents regarding suicidal actsUniversal prescription drug coverage in Canada: Long-promised yet undeliveredInfluence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in childrenA systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and developmentAssessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma.Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' dataThe h-e-B value-based health management program: impact on asthma medication adherence and healthcare cost.Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionEffects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis.Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β₂ -agonists in obstructive lung diseases: a population-based, observational studyEffects of changes in health insurance reimbursement level on outpatient service utilization of rural diabetics: evidence from Jiangsu Province, China.How patient cost-sharing trends affect adherence and outcomes: a literature review.Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines.Measuring drug exposure: concordance between defined daily dose and days' supply depended on drug classRelationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma.The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study.Impact of rosiglitazone meta-analysis on use of glucose-lowering medications.The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.
P2860
Q24188009-1FA9B007-EA94-4C5C-98EC-C64FC424C8AAQ24242490-59BEC787-033E-4BBB-BF3B-BC5AF482193EQ24594810-801D01F8-FC5D-40AC-B62B-BCBA7CE0BB16Q28069734-91F245DE-0F52-4425-B6CC-C9DA2DF88E4BQ28261327-6B11B466-96CD-4BA0-AE7F-AA28A2BB332CQ28540727-2BE4A0E6-2C83-40AC-B34D-06B343A349A6Q31060705-882F6388-651C-4552-8585-AF5A0858A022Q33353061-B394D25A-7698-46D1-9314-400B8FC3A61BQ33571327-2C80301A-3D3D-4CF7-A8FD-8E543F341CC9Q33932497-B9575B76-E242-4B97-9158-4EC48386FC09Q34001855-0EED147E-9BF8-401B-92FF-CA2661143969Q34001878-F8791F4F-17CC-4FDE-AFE3-23654CA7169FQ34001895-EEAFDFC0-3CC7-4215-A5C5-B00B0DB6E07DQ34967430-67038865-2E47-4C45-BAFC-229960610FB4Q35022943-1E145DAF-1F57-4CCC-8135-8EC06B997E6FQ35155778-E1B2DD5E-305A-489F-B9AE-A6DA71D06FDBQ35752951-35A9A9FE-273A-46BF-BD87-7B0A392D3748Q36387572-B236377F-4CE3-471B-945F-1949CDA92E64Q36938525-5DAB128D-2DE7-4D4F-B37C-9B2C006444C9Q37083290-03A0CD9C-7A65-4148-B7F4-5EA380E87DE2Q37735873-C4E37DE9-83DE-4999-9073-874AB515FE0AQ41807349-09010684-2F98-4708-A21E-89F1881ED3E2Q47160055-D9765DD8-4B86-43A7-B266-4333CC58954B
P2860
Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Impact of two sequential drug ...... e pulmonary disease or asthma.
@ast
Impact of two sequential drug ...... e pulmonary disease or asthma.
@en
type
label
Impact of two sequential drug ...... e pulmonary disease or asthma.
@ast
Impact of two sequential drug ...... e pulmonary disease or asthma.
@en
prefLabel
Impact of two sequential drug ...... e pulmonary disease or asthma.
@ast
Impact of two sequential drug ...... e pulmonary disease or asthma.
@en
P2093
P1476
Impact of two sequential drug ...... e pulmonary disease or asthma.
@en
P2093
Alan M Brookhart
Malcolm Maclure
Peter Neumann
Robert J Glynn
Sebastian Schneeweiss
P304
964-78; discussion 962-3
P356
10.1016/J.CLINTHERA.2006.06.007
P577
2006-06-01T00:00:00Z